e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
To treat or not to treat, and how? Sleep-disordered breathing I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome
Luisa Maria do Nascimento dos Santos (Mirandela, Portugal), Luísa Nascimento, Rita Gomes, Catia Saraiva, Marta Drummond
Source:
International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Session:
To treat or not to treat, and how? Sleep-disordered breathing I
Session type:
Thematic Poster Session
Number:
2395
Disease area:
Airway diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Luisa Maria do Nascimento dos Santos (Mirandela, Portugal), Luísa Nascimento, Rita Gomes, Catia Saraiva, Marta Drummond. PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome. Eur Respir J 2015; 46: Suppl. 59, 2395
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Related content which might interest you:
Long-term non-invasive ventilation in stable COPD patients reduces the rate of hospitalizations for exacerbation
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015
Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
May the obesity cause a better prognosis for domiciliary NIV prescribed COPD patients?
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Non invasive positive pressure ventilation for reducing exacerbation in very severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Exacerbation and hospitalization in COPD patients with long-term high-intensity NPPV
Source: Annual Congress 2007 - Technological progress in noninvasive ventilation
Year: 2007
Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015
Does obstructive lung disease impact the survival of patients with obesity-related respiratory failure treated with nocturnal NIV?
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
Non invasive positive pressure ventilation experience in Iran
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
COPD: Influence of patients’ nutritive status on the exacerbations rate
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
The use of the cyclical sigh function in long term non-invasive ventilation (NIV) as a method of lung volume recruitment to control hypercapnia in a patient with severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept